CorMedix (CRMD) Other Accumulated Expenses (2015 - 2025)

CorMedix has disclosed Other Accumulated Expenses across 11 years of filings, most recently posting $2.3 million for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $2.3 million, up 1749.19% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (up 1749.19% YoY), and the FY2025 annual result was $2.3 million, up 1749.19% from the prior year.
• Other Accumulated Expenses came in at $2.3 million for Q4 2025 at CorMedix, up from $278684.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.3 million in Q4 2025 to a low of $54763.0 in Q3 2023.
• The 5-year median for Other Accumulated Expenses is $112783.0 (2021), against an average of $242973.4.
• Peak annual rise in Other Accumulated Expenses reached 1749.19% in 2025, while the deepest fall reached 68.76% in 2025.
• CorMedix's Other Accumulated Expenses stood at $94736.0 in 2021, then sank by 31.96% to $64456.0 in 2022, then surged by 127.01% to $146324.0 in 2023, then retreated by 15.26% to $124000.0 in 2024, then soared by 1749.19% to $2.3 million in 2025.
• The last three Other Accumulated Expenses figures came in at $2.3 million (Q4 2025), $278684.0 (Q3 2025), and $136298.0 (Q2 2025), per Business Quant data.